Temocillin: is this the right momentum for its global use?

• Published in: Future microbiology Vol. 14; no. 2; pp. 81 - 83
• Main Authors: Balakrishnan, Indran, Koumaki, Vasiliki, Tsakris, Athanasios
• Format: Journal Article
• Language: English
• Published: England Future Medicine Ltd 01.01.2019
• Subjects: antibiotic resistance; Antibiotics; Antimicrobial agents; Azithromycin; Bacteria; Bacterial infections; Breakpoints; Carbapenemase; Ceftriaxone; Chemotherapy; Clinical isolates; Cystic fibrosis; Drug dosages; Drug resistance; E coli; Epidemiology; extended-spectrum β-lactamase; Gram-negative bacteria; Gram-positive bacteria; Minimum inhibitory concentration; Multidrug resistance; Temocillin; Urinary tract infections; β-lactams; Greece; England; United Kingdom > UK; Belgium; extended-spectrum β-lactamase; β-lactams; carbapenemase; antibiotic resistance

Published data on temocillin susceptibility rates are based on British Society for Antimicrobial Chemotherapy (BSAC) criteria for Enterobacteriaceae (susceptible at minimum inhibitory concentration [MIC] ≤ 8mg/l for systemic infections and ≤32mg/l for UTIs) (5), since neither Clinical and Laboratory...